Skip to main content
. 2018 Oct 1;2018(10):CD002252. doi: 10.1002/14651858.CD002252.pub4

Argentina 1987.

Methods Allocation concealment: not stated. Authors state "open randomised study". Two arms.
Participants 20 women with SBP > 159 mmHg and/or DBP > 99 mmHg x 2, 24 hrs apart, +/‐ proteinuria.
 Excluded: > 1 drug to control BP, or hypertensive emergency.
Interventions Exp: oral ketanserin 20 mg/day to 80 mg/day (10 women)
 Control: oral methyldopa 500 mg/day to 2000 mg/day (10 women)
Outcomes Women: none reported.
 Babies: stillbirth, neonatal death, birthweight (mean), gestation at delivery (mean).
Notes Interim report of study ongoing in 1987. Methods for measuring BP not mentioned.
Funding: no information about funding source.
Declaration of interests not described
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not described.
Allocation concealment (selection bias) Unclear risk Not described: quote: "...open randomised study..." no further details.
Blinding of participants and personnel (performance bias) 
 All outcomes High risk Open‐label trial.
Blinding of outcome assessment (detection bias) 
 All outcomes High risk No.
Incomplete outcome data (attrition bias) 
 All outcomes Low risk No.
Selective reporting (reporting bias) Unclear risk Assessment from published study report.
Other bias Unclear risk Groups appear comparable at baseline. No information about funding source. Declaration of interests not described.